Process View
Any process that modulates the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of macrophage derived foam cell differentiation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 1.000 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.994 | Human | |
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.901 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.754 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.699 | Human | |
| FHL2 | four and a half LIM domains 2 | 0.675 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.675 | Human | |
| COTL1 | coactosin-like 1 (Dictyostelium) | 0.581 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.549 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.544 | ||
| IL8 | interleukin 8 | 0.522 | ||
| TLN1 | talin 1 | 0.481 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.445 | ||
| FN1 | fibronectin 1 | 0.405 | ||
| RARA | retinoic acid receptor, alpha | 0.346 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.342 | Human | |
| ENG | endoglin | 0.313 | ||
| ATF2 | activating transcription factor 2 | 0.302 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.267 | Human | |
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.261 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.207 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.203 | Human | |
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.170 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.166 | Human | |
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.149 | Human | |
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.144 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.135 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.133 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.129 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.127 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.123 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.114 | Human | |
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.086 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.075 | Human | |
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.073 | ||
| HR | hairless homolog (mouse) | 0.071 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.068 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.067 | Human | |
| IL6 | interleukin 6 (interferon, beta 2) | 0.064 | ||
| THBS1 | thrombospondin 1 | 0.062 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.061 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.060 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.057 | Human | |
| JUN | jun proto-oncogene | 0.052 | ||
| CHUK | conserved helix-loop-helix ubiquitous kinase | 0.048 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.046 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.043 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.042 | ||
| CREBBP | CREB binding protein | 0.042 | ||
| PF4 | platelet factor 4 | 0.041 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.040 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.037 | ||
| ADAM9 | ADAM metallopeptidase domain 9 | 0.037 | ||
| CD63 | CD63 molecule | 0.034 | ||
| PXN | paxillin | 0.034 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.033 | Human | |
| IL1B | interleukin 1, beta | 0.031 | ||
| CHD9 | chromodomain helicase DNA binding protein 9 | 0.028 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.028 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.027 | ||
| CD9 | CD9 molecule | 0.024 | ||
| ATF3 | activating transcription factor 3 | 0.024 | ||
| EP300 | E1A binding protein p300 | 0.023 | ||
| CPNE6 | copine VI (neuronal) | 0.023 | ||
| HDAC3 | histone deacetylase 3 | 0.023 | ||
| UBD | ubiquitin D | 0.022 | ||
| MARCO | macrophage receptor with collagenous structure | 0.021 | ||
| RXRA | retinoid X receptor, alpha | 0.020 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.019 | Human | |
| ITGB4 | integrin, beta 4 | 0.019 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.019 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.019 | ||
| KRT5 | keratin 5 | 0.018 | ||
| FOSL1 | FOS-like antigen 1 | 0.018 | ||
| ITGB5 | integrin, beta 5 | 0.018 | ||
| PF4V1 | platelet factor 4 variant 1 | 0.017 | Human | |
| FLNA | filamin A, alpha | 0.017 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.017 | Human | |
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.017 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.016 | Human | |
| HIPK2 | homeodomain interacting protein kinase 2 | 0.015 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.015 | ||
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.015 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.015 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.015 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.014 | ||
| ALOXE3 | arachidonate lipoxygenase 3 | 0.014 | Human | |
| SLAMF8 | SLAM family member 8 | 0.013 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.013 | ||
| CUL7 | cullin 7 | 0.013 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.012 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.012 | ||
| APOC1 | apolipoprotein C-I | 0.012 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.012 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.012 | ||
| SIRT6 | sirtuin 6 | 0.012 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.011 | ||
| ITGA6 | integrin, alpha 6 | 0.011 | Human | |
| ALOX12B | arachidonate 12-lipoxygenase, 12R type | 0.010 | Human | |
| RUNX1 | runt-related transcription factor 1 | 0.010 | ||
| TLR7 | toll-like receptor 7 | 0.010 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.010 |